The impact of adjuvant therapy on survival for node-negative esophageal squamous cell carcinoma: a propensity score-matched analysis

BACKGROUND: At present, the primary treatment of esophageal cancer is surgery-based comprehensive treatment, including adjuvant therapy such as chemotherapy and/or radiotherapy. However, the role of adjuvant therapy for esophageal squamous cell carcinoma (ESCC) with pathologically node-negative (pN0...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Xuyang, He, Wenwu, Jiang, Yingchun, Deng, Sijie, Mao, Tianqin, Leng, Xuefeng, Luo, Qiyu, Zheng, Kai, Han, Yongtao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267332/
https://www.ncbi.nlm.nih.gov/pubmed/34277798
http://dx.doi.org/10.21037/atm-21-2539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267332/
https://www.ncbi.nlm.nih.gov/pubmed/34277798
http://dx.doi.org/10.21037/atm-21-2539

Ejemplares similares